Share:
SYDNEY, Dec. 15, 2020 /PRNewswire/ Clarity Pharmaceuticals, a clinical stage radiopharmaceutical company focused on the treatment of serious disease, is pleased to announce that it has completed a capital raising of $25,000,410.
Dr Alan Taylor, Executive Chairman of Clarity Pharmaceuticals, commented, It has been a pivotal year for Clarity with numerous critical milestones achieved in the development of our main products, advancement of our platform, as well as accelerated corporate and strategic activities despite facing an unprecedented global environment. The money raised will enable us to keep the momentum from 2020 going and provide financial resources to progress the following important initiatives:
Published: December 9, 2020
Fun, user-friendly, and more personal, with flexible learning opportunities, and great social events though missing in-person contact. These are the reactions of some members who attended INTA’s first-ever virtual Annual Meeting & Leadership Meeting in November.
The INTA Bulletin asked a group of mainly INTA Bulletins Committee members from various regions a set of questions going into the 2020 Annual Meeting & Leadership Meeting. Their responses give a revealing picture of the experiences of Meeting registrants. Overall? In addition to finding it “fun, user-friendly, and more personal,” they also noted the ease in making contacts and liked the opportunity to see a bit behind the business side of colleagues, into their homes and lives. The INTAconnect scheduling and networking system was a hit, along with the educational sessions and especially the social networking events.